Hospira works to grow its product offerings and keep its development pipeline flowing through a number of growth strategies including acquisitions, licensing deals, and partnered and independent R&D efforts.

To narrow its strategic focus, the company bundled its lower growth businesses into what was to become a separate company. Farmaceuticos y Hospitalarios, S.L. All Rights Reserved. Privacy Policy, Aragon, Lawrence, "Abbott Seeks Valley Expansion,", Barker, Robert, "Hospira Just May Put You in the Pink,", DeWitte, Dave, "Abbott Laboratories' Spinoff Hires Iowa Firm to Identify Top Health Products,", "Hospira Launches As New Independent, Global Hospital Products Co.,", Japsen, Bruce, "Former Workers Sue Abbott Over Spinoff of Hospital Products Unit,", ------, "Lake Forest, Ill.-Based Hospital Equipment Maker Sees 86 Percent Profit Gain,", Johnson, Ed, "Hospira Slumps As 2005 Outlook Spooks Investors,", Sikora, Martin, "U.S. Pension Law Violations Alleged in Abbott Spin-Off,". Subject to the Parties obtaining any required Consents, Abbott or the applicable Abbott Subsidiary shall assign to Hospira or the applicable Hospira Subsidiary that portion of any Shared IT Agreement that relates to the Hospira Business.

HOSPIRA AUSTRALIA PTY LTD has 559 total employees across all of its locations and generates $101.00 million in sales (USD). Although it lacked a name, the company was given a leader in August, a 17-year veteran of Abbott Laboratories, Christopher B. Begley. Begley responded by pointing out that Hospira, as a separate company, would receive more attention and more investment than it had under the control of Abbott Laboratories, noting, in a May 3, 2004 interview with CEO Wire, that Hospira "has been an under-funded business as it relates to research and development." PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. In one example of the increase in research and development spending, Begley set his sights on more than 30 injectable drugs scheduled to lose their patent protection in the first few years of Hospira's existence. In the late 1880s, Dr. Abbott began producing alkaloid extracts in pill form, a pioneering achievement that greatly increased the effectiveness of drugs such as morphine, quinine, strychnine, and codeine--all classified as alkaloid extracts.

4 - Subsidiaries List - Accession Number 0001047469-06-003426 - Filing - SEC SEC Info uses JavaScript! Global social, financial and environmental data, advertising and influence. Key customers include hospitals, alternate site facilities (such as nursing and outpatient surgical care facilities), wholesalers, and other drug manufacturers. When Hospira began trading on the New York Stock Exchange on May 3, 2004, the debut marked the start of a "new" company, a company with roots stretching back nearly 70 years. Abbott Laboratories' hospital products business never yielded big profits. Boehringer Ingelheim Pharmaceuticals, Inc.

Provider of medical supplies and infusion technology products. Hospira's first year as an independent company produced both encouraging and discouraging results.

The US market accounts for most of Hospira's annual revenues but the company's reach covers more than 70 countries on five continents. Employees (This Location): 700 By purchasing Hospira, Pfizer grew its Global Established Pharmaceutical segment, which specializes in sterile injectable products and biosimilars.

On a more positive note, important new products were developed that became one of Hospira's primary business platforms during the 21st century. It also runs 15 manufacturing facilities globally.

Hospira became the result, a division set free from the oversight of a company that had nurtured its development for seven decades. There are 757 companies in the Hospira Worldwide, LLC corporate family. For greater clarity, the Transferred Entities shall be deemed to have been Hospira Subsidiaries at all times prior to the Effective Time. To view pages properly, enable JavaScript in your browser. Combined, the group is one of the industry's leading biosimilars producers. From 1936 forward, Abbott Laboratories' hospital products division, relative to the company's other business interests, was a steady yet unprolific money winner. The company's most significant addition to its portfolio of interests happened by accident, a discovery that quickly became the financial bedrock of all of its operations and, in direct proportion to its importance, caused considerable pain to Abbott Laboratories when the discovery proved regrettable. The Roots of Hospira in the 1970s and 1980s. Hospira Worldwide, LLC has 2 total employees across all of its locations and generates $968,376 in sales (USD). Get the full list », To view Hospira’s complete subsidiaries history, request access », To view Hospira’s complete exits history, request access ». "We finished our first year as a public company on a strong note, delivering sales and earnings growth higher than we anticipated," he said. The company markets its products in other portions of the Americas, the Asia/Pacific region, and the EMEA region. Subsidiaries of Hospira, Inc. In 1984, the division introduced another innovation, a device for patient-controlled analgesia that enabled patients, for the first time, to control the administration of their pain medication. Thousands of ratings and reviews from the people that matter most — the employees, students and interns themselves. SVP Finance and CFO: Thomas E. Werner A Chicago native, Begley earned his undergraduate degree at Western Illinois University and a master's degree in business administration at Northern Illinois University.

Nearly 3.5 million bottles of intravenous solution were recalled after it was discovered that the bottles were sealed with a varnished paper called Golsonite that harbored bacteria. "While building on the momentum generated in 2004, we are still in a period of transition, and our focus in 2005 is on execution.

Hospira works to grow its product offerings and keep its development pipeline flowing through a number of growth strategies including acquisitions, licensing deals, and partnered and independent R&D efforts.

To narrow its strategic focus, the company bundled its lower growth businesses into what was to become a separate company. Farmaceuticos y Hospitalarios, S.L. All Rights Reserved. Privacy Policy, Aragon, Lawrence, "Abbott Seeks Valley Expansion,", Barker, Robert, "Hospira Just May Put You in the Pink,", DeWitte, Dave, "Abbott Laboratories' Spinoff Hires Iowa Firm to Identify Top Health Products,", "Hospira Launches As New Independent, Global Hospital Products Co.,", Japsen, Bruce, "Former Workers Sue Abbott Over Spinoff of Hospital Products Unit,", ------, "Lake Forest, Ill.-Based Hospital Equipment Maker Sees 86 Percent Profit Gain,", Johnson, Ed, "Hospira Slumps As 2005 Outlook Spooks Investors,", Sikora, Martin, "U.S. Pension Law Violations Alleged in Abbott Spin-Off,". Subject to the Parties obtaining any required Consents, Abbott or the applicable Abbott Subsidiary shall assign to Hospira or the applicable Hospira Subsidiary that portion of any Shared IT Agreement that relates to the Hospira Business.

HOSPIRA AUSTRALIA PTY LTD has 559 total employees across all of its locations and generates $101.00 million in sales (USD). Although it lacked a name, the company was given a leader in August, a 17-year veteran of Abbott Laboratories, Christopher B. Begley. Begley responded by pointing out that Hospira, as a separate company, would receive more attention and more investment than it had under the control of Abbott Laboratories, noting, in a May 3, 2004 interview with CEO Wire, that Hospira "has been an under-funded business as it relates to research and development." PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. In one example of the increase in research and development spending, Begley set his sights on more than 30 injectable drugs scheduled to lose their patent protection in the first few years of Hospira's existence. In the late 1880s, Dr. Abbott began producing alkaloid extracts in pill form, a pioneering achievement that greatly increased the effectiveness of drugs such as morphine, quinine, strychnine, and codeine--all classified as alkaloid extracts.

4 - Subsidiaries List - Accession Number 0001047469-06-003426 - Filing - SEC SEC Info uses JavaScript! Global social, financial and environmental data, advertising and influence. Key customers include hospitals, alternate site facilities (such as nursing and outpatient surgical care facilities), wholesalers, and other drug manufacturers. When Hospira began trading on the New York Stock Exchange on May 3, 2004, the debut marked the start of a "new" company, a company with roots stretching back nearly 70 years. Abbott Laboratories' hospital products business never yielded big profits. Boehringer Ingelheim Pharmaceuticals, Inc.

Provider of medical supplies and infusion technology products. Hospira's first year as an independent company produced both encouraging and discouraging results.

The US market accounts for most of Hospira's annual revenues but the company's reach covers more than 70 countries on five continents. Employees (This Location): 700 By purchasing Hospira, Pfizer grew its Global Established Pharmaceutical segment, which specializes in sterile injectable products and biosimilars.

On a more positive note, important new products were developed that became one of Hospira's primary business platforms during the 21st century. It also runs 15 manufacturing facilities globally.

Hospira became the result, a division set free from the oversight of a company that had nurtured its development for seven decades. There are 757 companies in the Hospira Worldwide, LLC corporate family. For greater clarity, the Transferred Entities shall be deemed to have been Hospira Subsidiaries at all times prior to the Effective Time. To view pages properly, enable JavaScript in your browser. Combined, the group is one of the industry's leading biosimilars producers. From 1936 forward, Abbott Laboratories' hospital products division, relative to the company's other business interests, was a steady yet unprolific money winner. The company's most significant addition to its portfolio of interests happened by accident, a discovery that quickly became the financial bedrock of all of its operations and, in direct proportion to its importance, caused considerable pain to Abbott Laboratories when the discovery proved regrettable. The Roots of Hospira in the 1970s and 1980s. Hospira Worldwide, LLC has 2 total employees across all of its locations and generates $968,376 in sales (USD). Get the full list », To view Hospira’s complete subsidiaries history, request access », To view Hospira’s complete exits history, request access ». "We finished our first year as a public company on a strong note, delivering sales and earnings growth higher than we anticipated," he said. The company markets its products in other portions of the Americas, the Asia/Pacific region, and the EMEA region. Subsidiaries of Hospira, Inc. In 1984, the division introduced another innovation, a device for patient-controlled analgesia that enabled patients, for the first time, to control the administration of their pain medication. Thousands of ratings and reviews from the people that matter most — the employees, students and interns themselves. SVP Finance and CFO: Thomas E. Werner A Chicago native, Begley earned his undergraduate degree at Western Illinois University and a master's degree in business administration at Northern Illinois University.

Nearly 3.5 million bottles of intravenous solution were recalled after it was discovered that the bottles were sealed with a varnished paper called Golsonite that harbored bacteria. "While building on the momentum generated in 2004, we are still in a period of transition, and our focus in 2005 is on execution.

Hospira works to grow its product offerings and keep its development pipeline flowing through a number of growth strategies including acquisitions, licensing deals, and partnered and independent R&D efforts.

To narrow its strategic focus, the company bundled its lower growth businesses into what was to become a separate company. Farmaceuticos y Hospitalarios, S.L. All Rights Reserved. Privacy Policy, Aragon, Lawrence, "Abbott Seeks Valley Expansion,", Barker, Robert, "Hospira Just May Put You in the Pink,", DeWitte, Dave, "Abbott Laboratories' Spinoff Hires Iowa Firm to Identify Top Health Products,", "Hospira Launches As New Independent, Global Hospital Products Co.,", Japsen, Bruce, "Former Workers Sue Abbott Over Spinoff of Hospital Products Unit,", ------, "Lake Forest, Ill.-Based Hospital Equipment Maker Sees 86 Percent Profit Gain,", Johnson, Ed, "Hospira Slumps As 2005 Outlook Spooks Investors,", Sikora, Martin, "U.S. Pension Law Violations Alleged in Abbott Spin-Off,". Subject to the Parties obtaining any required Consents, Abbott or the applicable Abbott Subsidiary shall assign to Hospira or the applicable Hospira Subsidiary that portion of any Shared IT Agreement that relates to the Hospira Business.

HOSPIRA AUSTRALIA PTY LTD has 559 total employees across all of its locations and generates $101.00 million in sales (USD). Although it lacked a name, the company was given a leader in August, a 17-year veteran of Abbott Laboratories, Christopher B. Begley. Begley responded by pointing out that Hospira, as a separate company, would receive more attention and more investment than it had under the control of Abbott Laboratories, noting, in a May 3, 2004 interview with CEO Wire, that Hospira "has been an under-funded business as it relates to research and development." PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. In one example of the increase in research and development spending, Begley set his sights on more than 30 injectable drugs scheduled to lose their patent protection in the first few years of Hospira's existence. In the late 1880s, Dr. Abbott began producing alkaloid extracts in pill form, a pioneering achievement that greatly increased the effectiveness of drugs such as morphine, quinine, strychnine, and codeine--all classified as alkaloid extracts.

4 - Subsidiaries List - Accession Number 0001047469-06-003426 - Filing - SEC SEC Info uses JavaScript! Global social, financial and environmental data, advertising and influence. Key customers include hospitals, alternate site facilities (such as nursing and outpatient surgical care facilities), wholesalers, and other drug manufacturers. When Hospira began trading on the New York Stock Exchange on May 3, 2004, the debut marked the start of a "new" company, a company with roots stretching back nearly 70 years. Abbott Laboratories' hospital products business never yielded big profits. Boehringer Ingelheim Pharmaceuticals, Inc.

Provider of medical supplies and infusion technology products. Hospira's first year as an independent company produced both encouraging and discouraging results.

The US market accounts for most of Hospira's annual revenues but the company's reach covers more than 70 countries on five continents. Employees (This Location): 700 By purchasing Hospira, Pfizer grew its Global Established Pharmaceutical segment, which specializes in sterile injectable products and biosimilars.

On a more positive note, important new products were developed that became one of Hospira's primary business platforms during the 21st century. It also runs 15 manufacturing facilities globally.

Hospira became the result, a division set free from the oversight of a company that had nurtured its development for seven decades. There are 757 companies in the Hospira Worldwide, LLC corporate family. For greater clarity, the Transferred Entities shall be deemed to have been Hospira Subsidiaries at all times prior to the Effective Time. To view pages properly, enable JavaScript in your browser. Combined, the group is one of the industry's leading biosimilars producers. From 1936 forward, Abbott Laboratories' hospital products division, relative to the company's other business interests, was a steady yet unprolific money winner. The company's most significant addition to its portfolio of interests happened by accident, a discovery that quickly became the financial bedrock of all of its operations and, in direct proportion to its importance, caused considerable pain to Abbott Laboratories when the discovery proved regrettable. The Roots of Hospira in the 1970s and 1980s. Hospira Worldwide, LLC has 2 total employees across all of its locations and generates $968,376 in sales (USD). Get the full list », To view Hospira’s complete subsidiaries history, request access », To view Hospira’s complete exits history, request access ». "We finished our first year as a public company on a strong note, delivering sales and earnings growth higher than we anticipated," he said. The company markets its products in other portions of the Americas, the Asia/Pacific region, and the EMEA region. Subsidiaries of Hospira, Inc. In 1984, the division introduced another innovation, a device for patient-controlled analgesia that enabled patients, for the first time, to control the administration of their pain medication. Thousands of ratings and reviews from the people that matter most — the employees, students and interns themselves. SVP Finance and CFO: Thomas E. Werner A Chicago native, Begley earned his undergraduate degree at Western Illinois University and a master's degree in business administration at Northern Illinois University.

Nearly 3.5 million bottles of intravenous solution were recalled after it was discovered that the bottles were sealed with a varnished paper called Golsonite that harbored bacteria. "While building on the momentum generated in 2004, we are still in a period of transition, and our focus in 2005 is on execution.

Hospira works to grow its product offerings and keep its development pipeline flowing through a number of growth strategies including acquisitions, licensing deals, and partnered and independent R&D efforts.

To narrow its strategic focus, the company bundled its lower growth businesses into what was to become a separate company. Farmaceuticos y Hospitalarios, S.L. All Rights Reserved. Privacy Policy, Aragon, Lawrence, "Abbott Seeks Valley Expansion,", Barker, Robert, "Hospira Just May Put You in the Pink,", DeWitte, Dave, "Abbott Laboratories' Spinoff Hires Iowa Firm to Identify Top Health Products,", "Hospira Launches As New Independent, Global Hospital Products Co.,", Japsen, Bruce, "Former Workers Sue Abbott Over Spinoff of Hospital Products Unit,", ------, "Lake Forest, Ill.-Based Hospital Equipment Maker Sees 86 Percent Profit Gain,", Johnson, Ed, "Hospira Slumps As 2005 Outlook Spooks Investors,", Sikora, Martin, "U.S. Pension Law Violations Alleged in Abbott Spin-Off,". Subject to the Parties obtaining any required Consents, Abbott or the applicable Abbott Subsidiary shall assign to Hospira or the applicable Hospira Subsidiary that portion of any Shared IT Agreement that relates to the Hospira Business.

HOSPIRA AUSTRALIA PTY LTD has 559 total employees across all of its locations and generates $101.00 million in sales (USD). Although it lacked a name, the company was given a leader in August, a 17-year veteran of Abbott Laboratories, Christopher B. Begley. Begley responded by pointing out that Hospira, as a separate company, would receive more attention and more investment than it had under the control of Abbott Laboratories, noting, in a May 3, 2004 interview with CEO Wire, that Hospira "has been an under-funded business as it relates to research and development." PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach. In one example of the increase in research and development spending, Begley set his sights on more than 30 injectable drugs scheduled to lose their patent protection in the first few years of Hospira's existence. In the late 1880s, Dr. Abbott began producing alkaloid extracts in pill form, a pioneering achievement that greatly increased the effectiveness of drugs such as morphine, quinine, strychnine, and codeine--all classified as alkaloid extracts.

4 - Subsidiaries List - Accession Number 0001047469-06-003426 - Filing - SEC SEC Info uses JavaScript! Global social, financial and environmental data, advertising and influence. Key customers include hospitals, alternate site facilities (such as nursing and outpatient surgical care facilities), wholesalers, and other drug manufacturers. When Hospira began trading on the New York Stock Exchange on May 3, 2004, the debut marked the start of a "new" company, a company with roots stretching back nearly 70 years. Abbott Laboratories' hospital products business never yielded big profits. Boehringer Ingelheim Pharmaceuticals, Inc.

Provider of medical supplies and infusion technology products. Hospira's first year as an independent company produced both encouraging and discouraging results.

The US market accounts for most of Hospira's annual revenues but the company's reach covers more than 70 countries on five continents. Employees (This Location): 700 By purchasing Hospira, Pfizer grew its Global Established Pharmaceutical segment, which specializes in sterile injectable products and biosimilars.

On a more positive note, important new products were developed that became one of Hospira's primary business platforms during the 21st century. It also runs 15 manufacturing facilities globally.

Hospira became the result, a division set free from the oversight of a company that had nurtured its development for seven decades. There are 757 companies in the Hospira Worldwide, LLC corporate family. For greater clarity, the Transferred Entities shall be deemed to have been Hospira Subsidiaries at all times prior to the Effective Time. To view pages properly, enable JavaScript in your browser. Combined, the group is one of the industry's leading biosimilars producers. From 1936 forward, Abbott Laboratories' hospital products division, relative to the company's other business interests, was a steady yet unprolific money winner. The company's most significant addition to its portfolio of interests happened by accident, a discovery that quickly became the financial bedrock of all of its operations and, in direct proportion to its importance, caused considerable pain to Abbott Laboratories when the discovery proved regrettable. The Roots of Hospira in the 1970s and 1980s. Hospira Worldwide, LLC has 2 total employees across all of its locations and generates $968,376 in sales (USD). Get the full list », To view Hospira’s complete subsidiaries history, request access », To view Hospira’s complete exits history, request access ». "We finished our first year as a public company on a strong note, delivering sales and earnings growth higher than we anticipated," he said. The company markets its products in other portions of the Americas, the Asia/Pacific region, and the EMEA region. Subsidiaries of Hospira, Inc. In 1984, the division introduced another innovation, a device for patient-controlled analgesia that enabled patients, for the first time, to control the administration of their pain medication. Thousands of ratings and reviews from the people that matter most — the employees, students and interns themselves. SVP Finance and CFO: Thomas E. Werner A Chicago native, Begley earned his undergraduate degree at Western Illinois University and a master's degree in business administration at Northern Illinois University.

Nearly 3.5 million bottles of intravenous solution were recalled after it was discovered that the bottles were sealed with a varnished paper called Golsonite that harbored bacteria. "While building on the momentum generated in 2004, we are still in a period of transition, and our focus in 2005 is on execution.